20/01/2020

Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia

  Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19 Mediche...

16/12/2019

Medichem Cares, Sustainable Environment

Sustainable Environment by Medichem

12/07/2019

Medichem’s R&D and Business Development summit in ESADECREAPOLIS

What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem's R&D and Business Development summit? On July 9th and 10th,...

05/07/2019

USP’s Donor Recognition Program would like to recognize Medichem for its contributions…

  "USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year" Says Ronald T. Pie...

05/07/2019

“Fostering The Culture of Innovation and Excellence”

  On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B. In line with Medichem´s Culture of Innovation, th...

30/04/2019

We are proud to announce that Medichem´s Rivaroxaban 2.5mg, 10mg, 15mg and 20 mg DCP has been approved! … And API Rivaroxaban EU and US DMFs have been successfully filed!

21/03/2019

First European APIs, Sugammadex and Apixaban, filed to the NMPA!